Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has a curative potential for many hematologic malignancies and blood diseases. However, the success of allo-HSCT is limited by graft-versus-host disease (GVHD), an immunological syndrome that involves inflammation and tissue damage media...

Full description

Bibliographic Details
Main Authors: Nancy Y. Villa, Masmudur M. Rahman, Grant McFadden, Christopher R. Cogle
Format: Article
Language:English
Published: MDPI AG 2016-03-01
Series:Viruses
Subjects:
cancer
hematopoietic cell transplant
allogeneic
allo-HSCT
GVHD
GVC
MYXV
Online Access:http://www.mdpi.com/1999-4915/8/3/85

Internet

http://www.mdpi.com/1999-4915/8/3/85

Similar Items